MPZL3 and ovarian cancer: In this study, we set out to explore the role of MPZL3 in ovarian cancer and found that loss of MPZL3 results in loss of homotypic cell adhesion and a more invasive phenotype associated with epithelial to mesenchymal transition (EMT).